Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 403
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Phenocoat 50 mg V/DCP/25/0015 Alfasan Nederland BV, Nīderlande QN03AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Phenobarbital
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0015-01 1 Blisteris, 10 tablete -
V/DCP/25/0015-02 2 Blisteris, 10 tablete -
V/DCP/25/0015-03 3 Blisteris, 10 tablete -
V/DCP/25/0015-04 4 Blisteris, 10 tablete -
V/DCP/25/0015-05 5 Blisteris, 10 tablete -
V/DCP/25/0015-06 6 Blisteris, 10 tablete -
V/DCP/25/0015-07 7 Blisteris, 10 tablete -
V/DCP/25/0015-08 8 Blisteris, 10 tablete -
V/DCP/25/0015-09 9 Blisteris, 10 tablete -
V/DCP/25/0015-10 10 Blisteris, 10 tablete -
V/DCP/25/0015-11 25 Blisteris, 10 tablete -
Ecomectin 10 mg/ml V/MRP/07/1684 ECO Animal Health Europe Limited, Īrija QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Battle, Hayward & Bower Ltd., Lielbritānija;Produlab Pharma b.v., Nīderlande;Divasa Farmavic S.A., Spānija
Date of authorisation/renewal: 09-Mar-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1684-01 10 mg/ml 1 ABPE flakons, 50 ml -
V/MRP/07/1684-02 10 mg/ml 1 ABPE flakons, 200 ml -
V/MRP/07/1684-03 10 mg/ml 1 ABPE flakons, 500 ml -
V/MRP/07/1684-04 10 mg/ml 1 PET flakons, 250 ml -
V/MRP/07/1684-05 10 mg/ml 1 PET flakons, 50 ml -
V/MRP/07/1684-06 10 mg/ml 1 PET flakons, 500 ml -
Rilexine 200 - V/NRP/07/1702 Virbac S.A., Francija QJ51DB01 lactating cows

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalexin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Virbac S.A., Francija;Haupt Pharma Latina s.r.l., Itālija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1702-01 200 mg 4 Injektors, 1 deva -
V/NRP/07/1702-02 200 mg 12 Injektors, 1 deva -
Surricoxx 400 mg/ml V/DCP/21/0009 V.M.D. n.v., Beļģija QP51BX02 ducks; turkeys; chickens; Guinea fowl Vairāk

Medicinal product information

Pharmaceutical form: solution for use in drinking water
International name (active substance): Amprolium hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release V.M.D. n.v., Beļģija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0009-01 400 mg/ml 1 ABPE pudele, 100 ml -
V/DCP/21/0009-02 400 mg/ml 1 ABPE pudele, 1 l -
V/DCP/21/0009-03 400 mg/ml 1 ABPE konteiners, 5 l -
Pimotab 1.25 mg V/MRP/21/0003 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0003-01 1,25 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0003-02 1,25 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0003-03 1,25 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimotab 2.5 mg V/MRP/21/0004 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0004-01 2,5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0004-02 2,5 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0004-03 2,5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimotab 5 mg V/MRP/21/0005 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0005-01 5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0005-02 5 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0005-03 5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimotab 10 mg V/MRP/21/0006 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0006-01 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0006-02 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/MRP/21/0006-03 10 Al/OPA/Al/PVH blisteris, 10 tablete -
Benamix 6.25 mg/g V/DCP/25/0020 VIRBAC, Francija QC09AA07 cats Vairāk

Medicinal product information

Pharmaceutical form: premix for medicated feeding stuff
International name (active substance): Benazepril hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 25-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0020-01 1 Kanna, 4,032 kg -
Pimotab 15 mg V/MRP/21/0007 CP-Pharma Handelsgesellschaft GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0007-01 15 mg 6 Al/OPA/Al/PVH blisteris, 5 tablete -
V/MRP/21/0007-02 15 mg 10 Al/OPA/Al/PVH blisteris, 5 tablete -
V/MRP/21/0007-03 15 mg 20 Al/OPA/Al/PVH blisteris, 5 tablete -
Mitex - V/DCP/15/0006 VetViva Richter GmbH , Austrija QS02CA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: ear drops and cutaneous suspension
International name (active substance): Miconazole nitrate, Prednisolone acetate, Polymyxin B sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 30-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0006-01 1 ZBPE pudelīte, 20 ml -
Pergoquin 1 mg V/DCP/19/0079 VetViva Richter GmbH , Austrija QN04BC02 horses Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Pergolide mesylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraks (24-Aug-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraks (24-Aug-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0079-01 1 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-02 1 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-03 1 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-04 1 mg 15 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-05 1 mg 16 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0079-06 1 mg 20 Al/OPA/Al/PVH blisteris, 10 tablete [PDF] [PDF] [DOCX]
Exagon 400 mg/ml V/DCP/14/0001 VetViva Richter GmbH , Austrija QN51AA01 tortoises; guinea pigs; hamsters; birds; poultry; cattle; pigs; horses; mouses; rats; dogs; cats; rabbits; minks; pigeons; ponies; snakes; lizards; frogs; hares; polecats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 31-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0001-01 400 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/14/0001-02 400 mg/ml 5 Stikla flakons, 100 ml -
Bupaq 0.3 mg/ml V/MRP/18/0042 VetViva Richter GmbH , Austrija QN02AE01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Buprenorphine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 28-Jun-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0042-01 3 Stikla flakons, 2 ml -
V/MRP/18/0042-02 4 Stikla flakons, 2 ml -
V/MRP/18/0042-03 5 Stikla flakons, 2 ml -
V/MRP/18/0042-04 6 Stikla flakons, 2 ml -
V/MRP/18/0042-05 10 Stikla flakons, 2 ml -
Butagran Equi 200 mg/g V/DCP/12/0072 Dopharma Research B.V., Nīderlande QM01AA01 horses Vairāk

Medicinal product information

Pharmaceutical form: oral powder
International name (active substance): Phenylbutazone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0072-01 200 mg/g 100 PET/LDPE/Al folijas/LDPE paciņa, 5 g -
V/DCP/12/0072-02 200 mg/g 20 PET/LDPE/Al folijas/LDPE paciņa, 5 g -
V/DCP/12/0072-03 200 mg/g 100 Al folijas/LDPE/papīra/LDPE paciņa, 5 g -
V/DCP/12/0072-04 200 mg/g 20 Al folijas/LDPE/papīra/LDPE paciņa, 5 g -
Synulox LC - V/MRP/98/0770 Zoetis Belgium S.A., Beļģija QJ51RV01 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Amoxicillin trihydrate, Prednisolone acetate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (31-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (31-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/98/0770-01 24 Injektors, 1 deva -
V/MRP/98/0770-02 300 Injektors, 1 deva -
V/MRP/98/0770-05 12 Injektors, 1 deva -
Enrobioflox 10% 100 mg/ml V/NRP/96/0284 Vetoquinol Biowet Sp. z o.o., Polija QJ01MA90 pigs; calves; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Enrofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z. o. o., Polija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 230818LI (23-Jul-2018)
Labelling text: [PDF] 230718M (23-Jul-2018)
Summary of product characteristics: [PDF] 230718ZA (23-Jul-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0284-01 100 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0284-02 100 mg/ml 1 Stikla flakons, 1000 ml -
Fipron 268 mg V/MRP/16/0023 Bioveta, a.s., Čehija QP53AX15 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 01-Feb-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 300117LI (01-Feb-2017)
Labelling text: [PDF] 300117M (01-Feb-2017)
Summary of product characteristics: [PDF] 300117ZA (01-Feb-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/16/0023-01 268 mg/deva 1 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0023-02 268 mg/deva 3 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0023-03 268 mg/deva 25 Polietilēna tūbiņa, 1 deva -
Fipron 50 mg V/MRP/16/0020 Bioveta, a.s., Čehija QP53AX15 cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 01-Feb-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 300117LI (01-Feb-2017)
Labelling text: [PDF] 300117M (01-Feb-2017)
Summary of product characteristics: [PDF] 300117ZA (01-Feb-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/16/0020-01 50 mg/deva 1 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0020-02 50 mg/deva 3 Polietilēna tūbiņa, 1 deva -
V/MRP/16/0020-03 50 mg/deva 25 Polietilēna tūbiņa, 1 deva -
TAbic IB VAR206 - V/MRP/19/0082 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: effervescent tablets
International name (active substance): Live attenuated Avian Infectious Bronchitis Virus, variant strain 2-06
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 27-Oct-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0082-01 1 PVH/PVDH blisteris, 500 deva -
V/MRP/19/0082-02 2 PVH/PVDH blisteris, 500 deva -
V/MRP/19/0082-03 1 PVH/PVDH blisteris, 1000 deva -
V/MRP/19/0082-04 2 PVH/PVDH blisteris, 1000 deva -
V/MRP/19/0082-05 1 PVH/PVDH blisteris, 2000 deva -
V/MRP/19/0082-06 2 PVH/PVDH blisteris, 2000 deva -
V/MRP/19/0082-07 1 PVH/PVDH blisteris, 5000 deva -
V/MRP/19/0082-08 2 PVH/PVDH blisteris, 5000 deva -
V/MRP/19/0082-09 1 PVH/PVDH blisteris, 10000 deva -
V/MRP/19/0082-10 2 PVH/PVDH blisteris, 10000 deva -
V/MRP/19/0082-11 1 PVH/PVDH blisteris, 2500 deva -
V/MRP/19/0082-12 2 PVH/PVDH blisteris, 2500 deva -
V/MRP/19/0082-13 1 PVH/PVDH blisteris, 1500 deva -
V/MRP/19/0082-14 2 PVH/PVDH blisteris, 1500 deva -
V/MRP/19/0082-15 1 PVH/PVDH blisteris, 3000 deva -
V/MRP/19/0082-16 2 PVH/PVDH blisteris, 3000 deva -
V/MRP/19/0082-17 1 PVH/PVDH blisteris, 3500 deva -
V/MRP/19/0082-18 2 PVH/PVDH blisteris, 3500 deva -
V/MRP/19/0082-19 1 PVH/PVDH blisteris, 4000 deva -
V/MRP/19/0082-20 2 PVH/PVDH blisteris, 4000 deva -

3082 records

© Food and veterinary service · 2026 Cookies policy